The global stomach cancer treatment market is on track for substantial expansion, with a projected market size of USD 11.47 billion by 2030. According to a recent market analysis, the market stood at USD 4.3 billion in 2022 and is anticipated to grow at a robust CAGR of 13% from 2023 to 2030.
Key Players
The major key players are Novartis AG, Pfizer, Inc., Mylan N.V., F. Hoffmann...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek